New ATMP certification process nears adoption
This article was originally published in Scrip
A new procedure intended to streamline the evaluation of advanced therapies from smaller biotech firms is expected to be in place within the next month or so.
You may also be interested in...
Roche plans to appeal against a penalty imposed by the Romanian competition authorities for implementing strategies that were said to delay the entry of competing biosimilar and generic products.
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
The latest drug safety actions by the European Medicines Agency affect products for dermatological use and vaginal atrophy.